INCYTE CORPORATION Defined Contribution Plan, Cost
INCYTE CORPORATION (INCY) reported Defined Contribution Plan, Cost of $6.40 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-04-28
- INCYTE CORPORATION defined contribution plan, cost for the quarter ending 2026-03-31 was $6.40M, a 10.34% increase year-over-year.
- INCYTE CORPORATION defined contribution plan, cost for the quarter ending 2025-12-31 was $5.10M, a 6.25% increase year-over-year.
- INCYTE CORPORATION defined contribution plan, cost for the quarter ending 2025-09-30 was $5.80M, a 11.54% increase year-over-year.
- INCYTE CORPORATION defined contribution plan, cost for the quarter ending 2025-06-30 was $5.70M, a 9.62% increase year-over-year.
- INCYTE CORPORATION defined contribution plan, cost for fiscal 2025 was $22.40M, a 8.74% increase from fiscal 2024.
- INCYTE CORPORATION defined contribution plan, cost for fiscal 2024 was $20.60M, a 8.99% increase from fiscal 2023.
- INCYTE CORPORATION defined contribution plan, cost for fiscal 2023 was $18.90M, a 1.07% increase from fiscal 2022.
- INCYTE CORPORATION defined contribution plan, cost for fiscal 2022 was $18.70M, a 11.98% increase from fiscal 2021.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 9 month | Defined Contribution Plan, Cost 12 month |
|---|---|---|---|---|
| 2026-03-31 | $6.40M 10-Q · filed 2026-04-28 | $11.50M derived: sum of 2 quarters · filed 2026-04-28 | $17.30M derived: sum of 3 quarters · filed 2026-04-28 | $23.00M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $10.90M derived: sum of 2 quarters · filed 2026-02-10 | $16.60M derived: sum of 3 quarters · filed 2026-02-10 | $22.40M 10-K · filed 2026-02-10 |
| 2025-09-30 | $5.80M 10-Q · filed 2025-10-28 | $11.50M derived: sum of 2 quarters · filed 2025-10-28 | $17.30M 10-Q · filed 2025-10-28 | $22.10M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $5.70M 10-Q · filed 2025-07-29 | $11.50M 10-Q · filed 2025-07-29 | $16.30M derived: sum of 3 quarters · filed 2026-04-28 | $21.50M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | $5.80M 10-Q · filed 2026-04-28 | $10.60M derived: sum of 2 quarters · filed 2026-04-28 | $15.80M derived: sum of 3 quarters · filed 2026-04-28 | $21.00M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $10.00M derived: sum of 2 quarters · filed 2026-02-10 | $15.20M derived: sum of 3 quarters · filed 2026-02-10 | $20.60M 10-K · filed 2026-02-10 |
| 2024-09-30 | $5.20M 10-Q · filed 2025-10-28 | $10.40M derived: sum of 2 quarters · filed 2025-10-28 | $15.80M 10-Q · filed 2025-10-28 | $20.10M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $5.20M 10-Q · filed 2025-07-29 | $10.60M 10-Q · filed 2025-07-29 | $14.90M derived: sum of 3 quarters · filed 2026-02-10 | $19.90M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $5.40M 10-Q · filed 2025-04-29 | $9.70M derived: sum of 2 quarters · filed 2026-02-10 | $14.70M derived: sum of 3 quarters · filed 2026-02-10 | $18.70M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $9.30M derived: sum of 2 quarters · filed 2026-02-10 | $13.30M derived: sum of 3 quarters · filed 2026-02-10 | $18.90M 10-K · filed 2026-02-10 |
| 2023-09-30 | $5.00M 10-Q · filed 2024-10-29 | $9.00M derived: sum of 2 quarters · filed 2024-10-29 | $14.60M 10-Q · filed 2024-10-29 | $18.60M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $4.00M 10-Q · filed 2024-07-30 | $9.60M 10-Q · filed 2024-07-30 | $13.60M derived: sum of 3 quarters · filed 2025-02-10 | $18.70M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | $5.60M 10-Q · filed 2024-04-30 | $9.60M derived: sum of 2 quarters · filed 2025-02-10 | $14.70M derived: sum of 3 quarters · filed 2025-02-10 | $19.40M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $9.10M derived: sum of 2 quarters · filed 2025-02-10 | $13.80M derived: sum of 3 quarters · filed 2025-02-10 | $18.70M 10-K · filed 2025-02-10 |
| 2022-09-30 | $5.10M 10-Q · filed 2023-10-31 | $9.80M derived: sum of 2 quarters · filed 2023-10-31 | $14.70M 10-Q · filed 2023-10-31 | $18.60M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $4.70M 10-Q · filed 2023-08-01 | $9.60M 10-Q · filed 2023-08-01 | $13.50M derived: sum of 3 quarters · filed 2024-02-13 | $17.90M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $4.90M 10-Q · filed 2023-05-02 | $8.80M derived: sum of 2 quarters · filed 2024-02-13 | $13.20M derived: sum of 3 quarters · filed 2024-02-13 | $17.50M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $8.30M derived: sum of 2 quarters · filed 2024-02-13 | $12.60M derived: sum of 3 quarters · filed 2024-02-13 | $16.70M 10-K · filed 2024-02-13 |
| 2021-09-30 | $4.40M 10-Q · filed 2022-11-01 | $8.70M derived: sum of 2 quarters · filed 2022-11-01 | $12.80M 10-Q · filed 2022-11-01 | $16.10M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $4.30M 10-Q · filed 2022-08-02 | $8.40M 10-Q · filed 2022-08-02 | $11.70M derived: sum of 3 quarters · filed 2023-02-07 | $15.20M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $4.10M 10-Q · filed 2022-05-03 | $7.40M derived: sum of 2 quarters · filed 2023-02-07 | $10.90M derived: sum of 3 quarters · filed 2023-02-07 | $14.20M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $6.80M derived: sum of 2 quarters · filed 2023-02-07 | $10.10M derived: sum of 3 quarters · filed 2023-02-07 | $13.40M 10-K · filed 2023-02-07 |
| 2020-09-30 | $3.50M 10-Q · filed 2021-11-02 | $6.80M derived: sum of 2 quarters · filed 2021-11-02 | $10.10M 10-Q · filed 2021-11-02 | $12.80M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $3.30M 10-Q · filed 2021-08-03 | $6.60M 10-Q · filed 2021-08-03 | $9.30M derived: sum of 3 quarters · filed 2022-02-08 | $12.30M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | $3.30M 10-Q · filed 2021-05-04 | $6.00M derived: sum of 2 quarters · filed 2022-02-08 | $9.00M derived: sum of 3 quarters · filed 2022-02-08 | $12.10M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $5.70M derived: sum of 2 quarters · filed 2022-02-08 | $8.80M derived: sum of 3 quarters · filed 2022-02-08 | $11.70M 10-K · filed 2022-02-08 |
| 2019-09-30 | $3.00M 10-Q · filed 2020-11-05 | $6.10M derived: sum of 2 quarters · filed 2020-11-05 | $9.00M 10-Q · filed 2020-11-05 | $11.40M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $3.10M 10-Q · filed 2020-08-04 | $6.00M 10-Q · filed 2020-08-04 | $8.40M derived: sum of 3 quarters · filed 2021-02-09 | $11.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $2.90M 10-Q · filed 2020-05-05 | $5.30M derived: sum of 2 quarters · filed 2021-02-09 | $7.90M derived: sum of 3 quarters · filed 2021-02-09 | $10.70M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $5.00M derived: sum of 2 quarters · filed 2021-02-09 | $7.80M derived: sum of 3 quarters · filed 2021-02-09 | $10.50M 10-K · filed 2021-02-09 |
| 2018-09-30 | $2.60M 10-Q · filed 2019-10-29 | $5.40M derived: sum of 2 quarters · filed 2019-10-29 | $8.10M 10-Q · filed 2019-10-29 | $10.30M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $2.80M 10-Q · filed 2019-07-30 | $5.50M 10-Q · filed 2019-07-30 | $7.70M derived: sum of 3 quarters · filed 2020-02-13 | $9.90M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $2.70M 10-Q · filed 2019-04-30 | $4.90M derived: sum of 2 quarters · filed 2020-02-13 | $7.10M derived: sum of 3 quarters · filed 2020-02-13 | $9.40M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $4.40M derived: sum of 2 quarters · filed 2020-02-13 | $6.70M derived: sum of 3 quarters · filed 2020-02-13 | $8.90M 10-K · filed 2020-02-13 |
| 2017-09-30 | $2.20M 10-Q · filed 2018-10-30 | $4.50M derived: sum of 2 quarters · filed 2018-10-30 | $6.70M 10-Q · filed 2018-10-30 | |
| 2017-06-30 | $2.30M 10-Q · filed 2018-07-31 | $4.50M 10-Q · filed 2018-07-31 | ||
| 2017-03-31 | $2.20M 10-Q · filed 2018-05-01 | |||
| 2016-12-31 | $6.60M 10-K · filed 2019-02-14 | |||
| 2015-12-31 | $2.90M 10-K · filed 2018-02-15 | |||
| 2014-12-31 | $2.40M 10-K · filed 2017-02-14 | |||
| 2013-12-31 | $1.90M 10-K · filed 2016-02-12 | |||
| 2012-12-31 | $1.70M 10-K · filed 2015-02-17 | |||
| 2011-12-31 | $900.00K 10-K · filed 2014-02-21 | |||
| 2010-12-31 | $700.00K 10-K · filed 2013-02-21 | |||
| 2009-12-31 | $600.00K 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |